Strength Seen in Pharmacyclics (PCYC): Stock Rises 10.1% - Analyst Blog

By Zacks Equity Research,

Shutterstock photo

Pharmacyclics Inc. ( PCYC ) was a big mover last session, as the company saw its shares increase more than 10% on the day. The move came on the back of solid volume too, as far more shares changed hands than in a normal session. This continues the recent uptrend for this drug manufacturer company as the stock is now up nearly 12% in the past one month time frame.

The company has seen 5 positive revisions in the past few weeks and its earnings consensus has moved up over the past two months, suggesting there could be more solid trading down the road for PCYC. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Pharmacyclics currently has a Zacks Rank #2 (Buy) and its Earnings ESP is positive.

Some better performing drug manufacturers include BioSpecifics Technologies Corp. ( BSTC ), Questcor Pharmaceuticals, Inc. ( QCOR ) and United Therapeutics Corporation ( UTHR ). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


PHARMACYCLICS (PCYC): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

UTD THERAPEUTIC (UTHR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Stocks
Referenced Stocks: BSTC , PCYC , QCOR , UTHR

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by